Form 8-K - Current report:
SEC Accession No. 0001140361-25-039793
Filing Date
2025-10-30
Accepted
2025-10-30 07:10:44
Documents
15
Period of Report
2025-10-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20057980_8k.htm   iXBRL 8-K 33223
2 EXHIBIT 3.2 ef20057980_ex3-2.htm EX-3.2 213229
3 EXHIBIT 99.1 ef20057980_ex99-1.htm EX-99.1 10890
7 image00002.jpg GRAPHIC 3046
  Complete submission text file 0001140361-25-039793.txt   438192

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rnac-20251029.xsd EX-101.SCH 3872
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnac-20251029_lab.xml EX-101.LAB 22692
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnac-20251029_pre.xml EX-101.PRE 16557
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20057980_8k_htm.xml XML 4224
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 251432176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)